MDGL logo

MDGL
Madrigal Pharmaceuticals Inc

6,846
Mkt Cap
$12.98B
Volume
245,761.00
52W High
$605.00
52W Low
$265.00
PE Ratio
-43.93
MDGL Fundamentals
Price
$560.55
Prev Close
$571.44
Open
$571.84
50D MA
$496.62
Beta
0.75
Avg. Volume
451,586.79
EPS (Annual)
-$21.90
P/B
20.73
Rev/Employee
$341,160.98
Loading...
Loading...
News
all
press releases
Marex Group plc Buys New Holdings in Madrigal Pharmaceuticals, Inc. $MDGL
Marex Group plc purchased a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the second quarter, according to the company in its most recent Form 13F filing...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 24,800 Shares of Stock
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Paul Friedman sold 24,800 shares of Madrigal Pharmaceuticals stock in a transaction on Wednesday, December 10th. The shares...
MarketBeat·2d ago
News Placeholder
Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells $10,297,597.50 in Stock
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 18,650 shares of Madrigal Pharmaceuticals stock in a transaction that occurred on Wednesday, December 10th...
MarketBeat·2d ago
News Placeholder
Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Rebecca Taub Sells 18,650 Shares
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 18,650 shares of the stock in a transaction on Wednesday, December 10th. The stock was sold at an average...
MarketBeat·2d ago
News Placeholder
Braidwell LP Has $18.40 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGL
Braidwell LP boosted its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 24.8% during the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·3d ago
News Placeholder
Madrigal Pharmaceuticals, Inc. $MDGL is Paulson & CO. Inc.'s Largest Position
Paulson & CO. Inc. cut its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 0.5% during the second quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Madrigal Pharmaceuticals, Inc. $MDGL Holdings Increased by Stempoint Capital LP
Stempoint Capital LP boosted its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 28.7% during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·5d ago
News Placeholder
Norges Bank Invests $53.41 Million in Madrigal Pharmaceuticals, Inc. $MDGL
Norges Bank purchased a new stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·10d ago
News Placeholder
JPMorgan Chase & Co. Buys 27,840 Shares of Madrigal Pharmaceuticals, Inc. $MDGL
JPMorgan Chase & Co. increased its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 99.4% during the 2nd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·10d ago
News Placeholder
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells 2,400 Shares of Stock
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) CEO William John Sibold sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, December 4th. The stock...
MarketBeat·10d ago
<
1
2
...
>

Latest MDGL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.